首例多发性骨髓瘤合并 COVID-19 患者经托珠单抗治疗后成功缓解。
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab.
机构信息
Department of Hematology, The First Affiliated Hospital of University of Science and Technology of China (USTC), Hefei, China.
Division of Life Sciences and Medicine, USTC, Hefei, China.
出版信息
Blood Adv. 2020 Apr 14;4(7):1307-1310. doi: 10.1182/bloodadvances.2020001907.
Abstract
We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.
摘要
我们报告了首例成功接受托珠单抗治疗的多发性骨髓瘤合并 2019 冠状病毒病（COVID-19）患者。尽管在本病例中托珠单抗对 COVID-19 的治疗有效，但仍需要开展随机对照试验。
Zotero 插件